Tofranil-pm vs. Strattera: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Tofranil-pm and Strattera. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 32,182 people who take Tofranil-pm and Strattera, and is updated regularly.
What is Tofranil-pm?
Tofranil-pm has active ingredients of imipramine pamoate. It is often used in depression. eHealthMe is studying from 50 Tofranil-pm users. Check the latest studies of Tofranil-pm.
What is Strattera?
Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,324 Strattera users. Check the latest studies of Strattera.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
32,182 people who take Tofranil-pm and Strattera are studied.
Drugs being compared in this study:
- Tofranil-Pm (imipramine pamoate)
- Strattera (atomoxetine hydrochloride)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Tofranil-Pm:
- not at all: 10.53 %
- somewhat: 21.05 %
- moderate: 31.58 %
- high: 26.32 %
- very high: 10.53 %
Strattera:
- not at all: 7.27 %
- somewhat: 26.99 %
- moderate: 38.82 %
- high: 20.26 %
- very high: 6.65 %
Want to compare Tofranil-pm with Strattera?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Tofranil-pm (19 reports)
- Strattera (27,428 reports)
Browse all side effects of Tofranil-pm:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Strattera:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on imipramine pamoate and atomoxetine hydrochloride (the active ingredients of Tofranil-pm and Strattera, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ketoprofen and Blood Alkaline Phosphatase Increased for Men aged 50-59 - 16 seconds ago
- Ventolin and Fistula for Women aged 40-49 - 24 seconds ago
- Tresiba and Pemphigoid for Women aged 60+ - 35 seconds ago
- Could Ingrezza cause Procedural Pain? - 43 seconds ago
- Morphine and Apallic Syndrome for Women aged 50-59 - a minute ago
- Carfilzomib and Muscle Spasm for Men aged 60+ - a minute ago
- Carfilzomib and Muscle Spasms for Men aged 60+ - a minute ago
- Could Tysabri cause Dehydration? - a minute ago
- Coq and Lexapro drug interactions for women aged 40-49 - a minute ago
- Cotrim and Ttp for Men aged 60+ - a minute ago